Results 241 to 250 of about 126,024 (329)

Data from Design and Reporting of Targeted Anticancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy

, 2023
James Mattina, Nathalie MacKinnon, Valerie C. Henderson, Dean Fergusson, Jonathan Kimmelman   +4 more
openalex   +1 more source

Navigating the Therapeutic Pathway and Optimal First-Line Systemic Therapy for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors. [PDF]

Medicina (Kaunas)
Shin HP, Lee M.
europepmc   +1 more source

Sorafenib tosylate for advanced kidney cancer: lucky loser and magic box at the same time

, 2011
Camillo Porta
openalex   +2 more sources

Risk of Arterial Thrombosis Not Increased by Sorafenib or Sunitinib [PDF]

, 2010
David R. Minor
openalex   +1 more source

circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis. [PDF]

MedComm (2020)
Ji L, Ruan Y, Tong M, Chen T, Cai J, Ye Z, Cai X, Xu J.   +7 more
europepmc   +1 more source

Safety and Efficacy of Sorafenib in Renal Cell Carcinoma [PDF]

, 2012
Julien Edeline, Élodie Vauléon, Nathalie Rioux‐Leclercq, Christophe Perrin, Cécile Vigneau Karim Bensalah, Brigitte Laguerre   +5 more
openalex   +1 more source

Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Reeves M, Chambers A, Shrestha A, Duarte S, Zarrinpar A, Malany S, Peddibhotla S.   +6 more
europepmc   +1 more source

RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma. [PDF]

J Biol Chem
Feng J, Ye L, Chen C, Zhu Y, Liu R, Yu H, Lu L, Gong K, Li W.   +8 more
europepmc   +1 more source

Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient Cohort. [PDF]

Pharmaceuticals (Basel)
Nazih M, Waked I, Abdelsattar S, Al-Amodi HS, Kamel HFM, Attia MM, Khoder AI, Hassan SB, Mahmoud Abdel-Latif M.   +8 more
europepmc   +1 more source

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma

EBioMedicine, 2020
Shun-jie Xia, Yu Pan, Yuelong Liang, Junjie Xu, Xiujun Cai   +4 more
semanticscholar   +1 more source